HSA recalls 8 brands of ranitidine products islandwide
The Singapore Health Sciences Authority (HSA) has recalled eight brands of ranitidine products containing trace amounts of the nitrosamine impurity NDMA*, which is a potential human carcinogen.
HSA recalls 8 brands of ranitidine products islandwide
03 Oct 2024